 
|
  |
  |
  |
 
|
  |
  |
| Overview |
|
At KAI, we are leveraging our core expertise in modulation of intracellular protein: protein interactions to advance product candidates quickly from preclinical research into clinical development. Our current clinical programs are focused in the areas of acute cardiovascular disease and metabolic bone disease (renal).
|
|||||||||||||||||||||||||||||||||||||||||||||||||
